Univista Edtech

Online Diploma in Pharmacovigilance & Drug Safety - Univista EdTech

At Univista EdTech, we tailor our approach to meet the unique needs of each learner.

Univista EdTech – the trusted choice of students and industry leaders alike.

Course Overview

The Online Diploma in Pharmacovigilance & Drug Safety by Univista EdTech is a comprehensive program designed to develop skilled professionals capable of monitoring, evaluating, and ensuring the safety of pharmaceutical products throughout their lifecycle.
This program provides in-depth knowledge of adverse event reporting, signal detection, risk management, and global pharmacovigilance regulations, enabling learners to play a critical role in patient safety and regulatory compliance.
Aligned with international standards such as ICH, WHO, EMA, USFDA, and MHRA, this diploma bridges scientific understanding with real-world safety operations, making graduates job-ready for careers in pharma, biotech, CROs, and regulatory organizations.

15 Months

INR 1,00,000

Intake: Year around admissions

Key Highlights

Complete understanding of global pharmacovigilance systems and safety regulations.

Learn from industry experts and drug-safety professionals with hands-on experience.

Practical exposure to case processing, signal detection, and risk-management plans.

Comprehensive modules on clinical trial safety, post-marketing surveillance, and ICSR documentation.

Integration of AI and digital tools used in pharmacovigilance workflows.

Capstone project involving a real-world pharmacovigilance case study or signal management plan.

Suitable for students and professionals in pharmacy, life sciences, medicine, or regulatory fields.

Skills You Will Learn

Adverse Event (AE) reporting and Individual Case Safety Report (ICSR) preparation.

Signal detection, risk assessment, and safety data analysis.

Regulatory compliance and documentation for global health authorities.

Pharmacovigilance data management and safety database navigation.

Clinical trial safety monitoring and expedited reporting.

Literature screening and periodic safety update reporting (PSUR/PBRER).

Communication of benefit–risk evaluations to stakeholders.

Quality control, audit readiness, and standard operating procedures (SOPs).

Tools You’ll Master

Course Outcomes

Learning Outcomes

Key Outcomes

Course Curriculum

Module 1

Introduction to Pharmacovigilance and Global Drug Safety Systems

Regulatory Guidelines – ICH, WHO, EMA, USFDA, CDSCO

Clinical Trial Safety Management and Expedited Reporting

Individual Case Safety Reports (ICSRs) – Collection to Submission

Signal Detection, Evaluation & Risk Assessment

Literature Screening, Aggregate Reporting (PSUR, PBRER)

Safety Databases and Documentation Management Systems

Audits, Compliance & Pharmacovigilance Quality Systems

Automation and AI in Pharmacovigilance – Emerging Trends

Capstone Project – Safety Audit or Signal Management Case Study

Why You Should Join this Course

₹1,00,000

Admissions Open

Eligibility

Admission Criteria

Join Us by Creating Account or Start a Free Trial

At Univista EdTech, we believe that higher education should not be a pause in your career—it should be a powerful step forward.